Intravenous (IV) Therapy and Vein Access: Global Markets

Intravenous (IV) Therapy and Vein Access: Global Markets

  • June 2017 •
  • 227 pages •
  • Report ID: 297995
• The global intravenous (IV) therapy and vein access market should reach $29 billion by 2021 from $21.6 billion in 2016 at a compound annual growth rate (CAGR) of 6.1%, from 2016 to 2021.
• Infusion pump market is expected to grow from $10.6 billion in 2016 to $14.2 billion in 2021 at a CAGR of 6.1% for the period 2016-2021.
• The vein access devices (IV catheters) market is expected to grow from $2.2 billion in 2016 to $3 billion in 2021 at a CAGR of 6.9% for the period 2016-2021.

Chapter 1: Introduction

Study Goals and Objectives
Intravenous (IV) therapy and vein access devices are an integral part of today’s treatment for various diseases. It is widely used in health care facilities for both surgical and nonsurgical patients. IV therapy is an important tool for fluid volume and electrolyte replacement, for the delivery of medications such as antibiotics and chemotherapeutic agents and for the administration of parenteral nutrition. BCC Research’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for IV therapy and vein access devices. The key objective is to present a comprehensive analysis and future direction of IV therapy and vein access devices as treatment option in various care facilities.

This report explores present and future strategies within the IV therapy and vein access devices market, which includes categories such as, IV solutions and sets, infusion pumps and vein access devices. The developments in the market, the setbacks and the needs of the market are discussed in this report. The
classifications, comparisons and usage of these types of devices are also detailed in this report. A detailed analysis of the IV therapy and vein access devices industry structure has been conducted. Revenues are broken down by the region, while sales figures are estimated for the five-year period from 2016 through 2021. Market by application in various care facilities for IV therapy and vein access devices is also discussed separately in the report, which also includes significant patents and their allotments in each category.

Reasons for Doing This Study
In recent years, people are living longer and there is an associated increase in ailments and various health issues. With the increase in disease incidence rates, the demand for medical interventions and treatments has also grown. This has influenced the intravenous (IV) therapy and vein access devices market and is expected to grow at a steady rate. The demand for all types of cost-effective IV therapy products and vein access devices is increasing. IV therapy and vein access products are mainly used in three types of care facility settings: hospitals, alternative sites and home. Many big and small health care facilities have started investing in modern IV therapy and vein access devices. Research and development (R&D) spending, along with increasing competition, patent expiries and new technologies are driving this market. Other market forces include advancements, new product launches and the changing lifestyles. This study looks at almost all the systems affected by these factors. Acquisition strategies and collaborations by companies are also covered in this report. In addition, the
strengths and weaknesses of each type in light of the new technologies, growing competition, and changing customer needs are also discussed.

Intended Audience
This study contributes to the areas of market growth in IV therapy and vein access devices manufacturers and users. Various health care facilities, research centers, academic institutions, government and private laboratories, physicians as well as pharmaceutical, diagnostic and biotechnology companies will find this study to be of interest.

Scope of the Report
Growing emphasis on cost-effectiveness and cost-containment at health care facilities along with technological advances have enabled the safe and effective use of IV therapies. This is driving steady growth of the IV therapy and vein access devices market. This report focuses on the global market of IV therapy and vein access devices and provides an updated review that includes applications in various care facility settings. The scope of this study encompasses different types of IV solutions and devices used for therapeutic purposes. BCC Research studied and analyzed the market for key components including different types
of intravenous solutions and sets, infusion pumps and vein access devices (IV catheters). This report covers the associated regulatory aspects such as innovations and technological improvements (patents and approvals), latest trends, preferences and progress in the field of IV therapy. In addition, the study
also covers the market projections, market leaders and market shares for the global IV therapy market. The geographical regions covered in the report are North America, Europe and emerging markets. The emerging markets cover countries such as India, China, Japan, South Korea, Taiwan, Africa, Australia, New Zealand, etc.

This report also contains relevant patent analysis and comprehensive company profiles for leaders in the IV therapy and vein access devices industry. The market is dominated by a few major players including B. Braun Melsungen AG; Baxter International Inc.; Becton Dickinson and Co. (CareFusion Corp.); C. R. Bard,
Inc.; Fresenius Kabi AG; Hospira Inc. (now part of ICU Medical Inc.); Medtronic plc.; Smiths Group plc. (Smiths Medical) and Teleflex Inc.

Information Sources
Many companies were surveyed to obtain data for this study, including manufacturers and end users of IV therapy and vein access devices. Data were gathered from various industry sources. BCC interviewed industry officials, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

Both primary and secondary research methodologies were used in the preparation of this report. BCC Research conducted a comprehensive search of available literature, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers and users of IV therapy and vein access devices. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

Geographic Breakdown
In this report, the geographic regions considered for market analysis include:

North America
• United States
• Mexico
• Canada

• France
• Germany
• Italy
• United Kingdom
• Spain etc.

• China
• India
• Brazil
• Japan
• South Korea
• Africa
• Taiwan
• New Zealand, etc.

Country=World Industry=DrugDelivery ParentIndustry=LifeSciences Date=201706 Publisher=BCCResearch Price=5000